Dimethylformamide → 1-[4-(2-Methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazol-2-ylmethyl)piperazin-1-yl]-2-(4-tolyl)ethanone
Reaction equation
Cl.Cl.[CH3:3][C:4]1([CH2:15][N:16]2[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]2)[O:8][C:7]2=[N:9][C:10]([N+:12]([O-:14])=[O:13])=[CH:11][N:6]2[CH2:5]1.CN(C=O)C.C(N(CC)CC)C.[C:34]1([CH3:44])[CH:39]=[CH:38][C:37]([CH2:40][C:41](O)=[O:42])=[CH:36][CH:35]=1>C(OCC)(=O)C>[CH3:3][C:4]1([CH2:15][N:16]2[CH2:17][CH2:18][N:19]([C:41](=[O:42])[CH2:40][C:37]3[CH:38]=[CH:39][C:34]([CH3:44])=[CH:35][CH:36]=3)[CH2:20][CH2:21]2)[O:8][C:7]2=[N:9][C:10]([N+:12]([O-:14])=[O:13])=[CH:11][N:6]2[CH2:5]1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of 2-Methyl-6-nitro-2-(piperazin-1-ylmethyl)-2,3-dihydroimidazo[2,1-b]oxazole dihydrochloride prepared in Example 322 (240 mg, 0.79 mmol), DMF (5 ml) and triethylamine (0.22 ml, 1.58 mmol) was added p-tolylacetic acid (140 mg, 0.93 mmol) and WSCD (180 mg, 0.93 mmol) in this order followed by stirring at room temperature for 1 hour. The reaction mixture was diluted with ethyl acetate, washed with water twice, a saturated sodium hydrogencarbonate solution and a saturated saline solution in this order, dried over sodium sulfate and then filtered. The filtrate was concentrated under reduced pressure, and the residue was treated with diethylether to afford 1-[4-(2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazol-2-ylmethyl)piperazin-1-yl]-2-(4-tolyl)ethanone (172 mg, yield 64%) as a white powder.
Workup
- washwashed with water twice
- dry with materiala saturated sodium hydrogencarbonate solution and a saturated saline solution in this order, dried over sodium sulfate
- filtrationfiltered
- concentrationThe filtrate was concentrated under reduced pressure
- additionthe residue was treated with diethylether
Sources & evidence
- ORD record
- ord-81461e1c0d14473286319e46038ff145
- Source dataset
- uspto-grants-2007_08
- Patent number
- US07262212B2
Reaction notes
Loading…